Hemispherx Biopharma (HEB)
Hemispherx Biopharma EBITDA Margin TTM: -8484%
View HEB EBITDA Margin TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
HEB EBITDA Margin TTM Rankings
| Overall | 0th percentile | 3843 of 3848 |
| Sector | 0th percentile | 447 of 450 in Healthcare |
| Industry | 1st percentile | 120 of 122 in Biotechnology |
HEB EBITDA Margin TTM Range, Past 5 Years
| Minimum | -12680% | Mar 2010 |
| Maximum | -1735% | Jun 2007 |
| Average | -6885% |
About EBITDA Margin (TTM)
The EBITDA Margin is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.
Investors look at this measurement to get a closer approximation of performance of the business relative to sales before adjusting for the capital structure of the business (debt vs. equity financing).
Though many investors use EBITDA for this reason, some argue that the exclusion of depreciation expenses fails to capture the ongoing economics of a business since depreciation expenses are a good proxy for the replacement costs of property, plant and equipment, which must be paid in the future to continue business operations.
Learn More
You may also be interested in these HEB related companies
HEB News
$HEB maybe Carter can put Ampligen in e-cigarettes now that it's 2012 since he already explored putting it in real cigarettes in the 1980's
about 22 days ago by HankHill
about 22 days ago by HankHill
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2012
May 07, 4:35PM GlobeNewswire
May 07, 4:35PM GlobeNewswire
$heb ever hold a stock so you could laugh at it every day ? i have
about 40 days ago by roadkingtrdr
about 40 days ago by roadkingtrdr
Hemispherx Biopharma, Inc. to Host 2011 Year End Conference Call on Thursday, March 22, 2012
Mar 20, 8:30AM GlobeNewswire
Mar 20, 8:30AM GlobeNewswire
$HEB Cross over coming also a Triple top breakout at stockcharts.com on the P&F.
about 72 days ago by rtk
about 72 days ago by rtk
Hemispherx Publishes Data on the Bioactivity of Ampligen(R) in Chronic Fatigue Syndrome ("CFS")
Mar 19, 8:30AM GlobeNewswire
Mar 19, 8:30AM GlobeNewswire
$HEB , I am early but bot it this morning. loking for a nice pop
about 117 days ago by 3DTRADINGTRADER
about 117 days ago by 3DTRADINGTRADER
Hemispherx Biopharma Receives U.S. Patent Office Notification of Two New Patents Granted for Alferon(R) LDO
Jan 17, 8:30AM GlobeNewswire
Jan 17, 8:30AM GlobeNewswire
Hemispherx Biopharma (HEB) Recieves FDA Extension for NDA for Treatment of Chronic Fatigue Syndrome
Jan 11, 8:35AM Street Insider
Jan 11, 8:35AM Street Insider
$HEB shares up 14% following extension to modify NDA for treatment of CFS
about 140 days ago by Street_Insider
about 140 days ago by Street_Insider
Hemispherx Biopharma (HEB) Gets Extension from FDA for CFS NDA Modification
Jan 11, 8:31AM Street Insider
Jan 11, 8:31AM Street Insider
FDA Grants $HEB Extension in Its Pending New Drug Application for the Treatment of Chronic Fatigue
about 140 days ago by Benzinga
about 140 days ago by Benzinga
Hemispherx Biopharma Announces Further Adjournment on Proposal Number 4 From the 2011 Annual Meeting of Stockholders
Nov 09, 4:13PM GlobeNewswire
Nov 09, 4:13PM GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended September 30, 2011
Nov 09, 12:26PM GlobeNewswire
Nov 09, 12:26PM GlobeNewswire
Hemispherx Biopharma, Inc. to Host Conference Call on Chronic Fatigue Syndrome Progress Thursday, October 27, 2011
Oct 24, 10:22AM GlobeNewswire
Oct 24, 10:22AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HEB | 0.278 | +0.01 | +2.96% | 36.67M |
| HEAT | 4.04 | +0.00 | +0.00% | 15.59M |
| HE | 27.47 | +0.27 | +0.99% | 2.617B |
| HDY | 0.80 | -0.09 | -10.12% | 148.49M |
| HDSN | 3.96 | +0.11 | +2.86% | 91.55M |
| HDNG | 9.89 | +0.15 | +1.54% | 113.67M |
| HDG | 38.28 | +0.12 | +0.32% | |
| HDB | 29.36 | +0.76 | +2.66% | 22.18B |
| HD | 49.78 | +0.34 | +0.69% | 75.39B |
| HCSG | 19.97 | +0.24 | +1.24% | 1.319B |
